CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4 Shares withheld for taxes President & CEO gave up 4,319 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People Officer gave up 1,301 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,301 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,301 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 4 Option exercise Director acquired 712 shares (option exercise)
- 4 Grant or award Director acquired 1,568 shares (grant or award)
- 4 Grant or award Director acquired 1,763 shares (grant or award)
- 4 Grant or award Director acquired 1,725 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 819 shares (grant or award)
- 4 Grant or award Director acquired 1,265 shares (grant or award)
- 4 Grant or award Director acquired 1,150 shares (grant or award)
- 8-K/A Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 17 of 28 · 549 filings